Stock of the Day

Qiagen (QGEN)

$45.57

+$0.01 (+0.0%)

Market Cap: $10.14B

About Qiagen

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life.

The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

Recent News

• Tracer Biotechnologies Announces Strategic Partnership with QIAGEN to Advance Blood-Based MRD Testing for Solid Tumors (businesswire.com)
• Qiagen N.V. (QGEN) Expands MRD Testing with Tracer and Foresight Partnerships (insidermonkey.com)
• QIAGEN expands portfolio for MRD testing in oncology with two partnerships (msn.com)
• QIAGEN expands portfolio for minimal residual disease (MRD) testing in oncology with new strategic partnerships (businesswire.com)
• Foresight Diagnostics and QIAGEN Announce Strategic Partnership to Advance Development of Companion Diagnostic Kits for Lymphoma (prnewswire.com)